These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23912348)

  • 21. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
    Nakai K; Mineishi S; Kami M; Saito T; Hori A; Kojima R; Imataki O; Hamaki T; Yoshihara S; Ohnishi M; Kim SW; Ando T; Fumitoh A; Kanda Y; Makimoto A; Tanosaki R; Kanai S; Heike Y; Ohnishi T; Kawano Y; Wakasugi H; Takaue Y
    Transplantation; 2003 Jun; 75(12):2135-43. PubMed ID: 12829926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reader comments on antithymocyte globulin use for aplastic anemia.
    Eisenberg S
    Clin J Oncol Nurs; 2004 Dec; 8(6):583; author reply 583. PubMed ID: 15637953
    [No Abstract]   [Full Text] [Related]  

  • 23. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.
    Bacigalupo A
    Bone Marrow Transplant; 2005 Feb; 35(3):225-31. PubMed ID: 15558041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
    Graf Finckenstein F; Zabelina T; Dürken M; Dahlke J; Kröger N; Krüger W; Janka-Schaub G; Erttmann R; Zander AR; Kabisch H
    Klin Padiatr; 2002; 214(4):206-11. PubMed ID: 12165903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of acute graft-versus-host disease.
    Neudorf S; Filipovich A; Ramsay N; Kersey J
    Semin Hematol; 1984 Apr; 21(2):91-100. PubMed ID: 6377502
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
    Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
    Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease.
    Ballesteros M; Ferrá C; Serrano D; Batlle M; Ribera JM; Díez-Martín JL
    Am J Hematol; 2008 Oct; 83(10):824-5. PubMed ID: 18683868
    [No Abstract]   [Full Text] [Related]  

  • 29. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.
    Roy J; McGlave PB; Filipovich AH; Miller WJ; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1992 Jul; 10(1):77-82. PubMed ID: 1515883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antilymphocyte Globulin for Chronic Graft-versus-Host Disease.
    Imataki O; Uemura M; Kadowaki N
    N Engl J Med; 2016 May; 374(19):1894. PubMed ID: 27168442
    [No Abstract]   [Full Text] [Related]  

  • 32. Antilymphocyte Globulin for Chronic Graft-versus-Host Disease.
    Kröger N; Solano C; Bonifazi F
    N Engl J Med; 2016 May; 374(19):1894-5. PubMed ID: 27168441
    [No Abstract]   [Full Text] [Related]  

  • 33. [The comparison of fludarabine or antithymocyte globulin based non-myeloablative conditioning regimen for haematologic diseases with graft-versus-host disease].
    Li QS; Zhuang XY; Mao P
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):555-7. PubMed ID: 22338182
    [No Abstract]   [Full Text] [Related]  

  • 34. Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).
    Bacigalupo A; Oneto R; Lamparelli T; Gualandi F; Bregante S; Raiola AM; Di Grazia C; Dominietto A; Romagnani C; Bruno B; Van Lint MT; Frassoni F
    Bone Marrow Transplant; 2001 Dec; 28(12):1093-6. PubMed ID: 11803348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
    Willemze R; Richel DJ; Falkenburg JH; Hale G; Waldmann H; Zwaan FE; Fibbe WE
    Bone Marrow Transplant; 1992 Apr; 9(4):255-61. PubMed ID: 1600413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
    Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competing risks and multistate models.
    Schmoor C; Schumacher M; Finke J; Beyersmann J
    Clin Cancer Res; 2013 Jan; 19(1):12-21. PubMed ID: 23172882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra.
    Petropoulou AD; Robin M; Socié G; Galicier L
    Transplantation; 2010 Jul; 90(1):102-3. PubMed ID: 20606570
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of aplastic anemia.
    Gale RP
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.